Related Experiment Videos
Decrease in hepatic CYP2C11 mRNA and increase in heme oxygenase activity after intracerebroventricular injection of
Y Shimamoto1, T Tasaki, H Kitamura
1Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
The Journal of Veterinary Medical Science
|July 29, 1999
Summary
Intracerebroventricular injection of bacterial lipopolysaccharide (LPS) down-regulates rat liver CYP2C11 gene expression. This decrease in CYP2C11 mRNA and increased heme degradation may reduce CYP2C11 protein and activity.
Area of Science:
- Toxicology
- Molecular Biology
- Pharmacology
Background:
- Bacterial lipopolysaccharide (LPS) affects hepatic cytochrome P450 (CYP) isozymes.
- Intracerebroventricular (i.c.v.) LPS injection impacts CYP isozymes differently than intraperitoneal (i.p.) injection.
- CYP2C11, a male-specific isozyme, is particularly sensitive to i.c.v. LPS.
Purpose of the Study:
- To investigate the effects of i.c.v. and i.p. LPS on CYP2C11 gene expression, protein, and activity.
- To determine the impact of LPS on total P450 content and heme oxygenase (HO) activity.
- To elucidate the mechanism of LPS-induced downregulation of CYP2C11.
Main Methods:
- Rats received i.c.v. or i.p. injections of LPS or saline.
- Measurements included CYP2C11 mRNA, total P450 content, CYP2C11-dependent imipramine N-demethylase (IMND) activity, CYP2C11 protein, and HO activity.
- Analysis was performed on rat liver microsomes 10 hours post-injection.
Main Results:
- i.c.v. LPS significantly decreased CYP2C11 mRNA, total P450 content, and IMND activity.
- i.p. LPS at the same dose did not significantly affect these parameters.
- HO activity increased following both i.c.v. and i.p. LPS injections.
Conclusions:
- i.c.v. LPS down-regulates CYP2C11 expression at the transcriptional level.
- Decreased CYP2C11 mRNA and increased heme degradation contribute to reduced CYP2C11 protein and activity.
- The route of LPS administration influences its effect on hepatic CYP isozymes.